Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitors.

Both CXCL16 and CCL5 demonstrated increased levels in peripheral blood and tumors following treatment with gemcitabine, although some of the results did not reach statistical significance ( Figure S11A-B ).

also in 111,027 other papers